Trial record 9 of 11 for:
vpm1002
Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South Africa
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01113281 |
|
Recruitment Status :
Completed
First Posted : April 29, 2010
Last Update Posted : November 21, 2011
|
Sponsor:
Vakzine Projekt Management GmbH
Collaborators:
Farmovs-Parexel Bloemfontein, Republic of South Africa (Clinical Site)
Triclinium Johannesburg, RSA (Monitoring and Overall Management of the study)
University of Stellenbosch
HJ-CTC George, RSA (Statistics & Report)
Information provided by (Responsible Party):
Vakzine Projekt Management GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | December 2010 |
| Actual Study Completion Date : | March 2011 |